Treatment methods using homeopathic preparations of growth factors
AssigneeNone recorded
InventorBarbara A. Brewitt
Life of this patent
Estimating the term…
Loading patent…
AssigneeNone recorded
InventorBarbara A. Brewitt
Estimating the term…
The present invention comprises homeopathic preparations of growth factors, cyclins, and methods for their use. Disorders which may be effectively treated with the compositions of the present invention include chronic viral disorders, such as HIV, AIDS, chronic fatigue syndrome and Epstein-Barr viral infections, cancer, diabetes, depression, and autism. Homeopathic preparations of growth factors and/or cyclins are preferably administered orally. In an alternative embodiment, patients are treated with radio frequency signals corresponding to homeopathic dilutions of growth factors.
A method for treating disorders selected from the group consisting of chronic viral infections, cancer, diabetes, autism, and depression comprising administering a homeopathic preparation of one or combinations of growth factors, or one or combinations of cyclins and combinations of one or more growth factors with cyclins, said growth factors comprising cell signaling polypeptides.
A method for modifying calcium levels in a patient comprising administering a homeopathic preparation of one or combinations of growth factors, or one or combinations of cyclins and combinations of one or more growth factors with cyclins, said growth factors comprising cell signaling polypeptides.
A method for modifying phosphorus levels in a patient comprising administering a homeopathic preparation of one or combinations of growth factors, or one or combinations of cyclins and combinations of one or more growth factors with cyclins, said growth factors comprising cell signaling polypeptides.
A method for increasing platelet counts in HIV-positive patients with idiopathic thrombocytopenia purpura comprising administering a homeopathic preparation of one or combinations of growth factors, or one or combinations of cyclins and combinations of one or more growth factors with cyclins, said growth factors comprising cell signaling polypeptides.
Dependencies are inferred from the claim text.
Drawings are temporarily unavailable. Open the PDF at USPTO
From the US filing history. Foreign family members aren’t listed.
Backward citations are indexed for grants only.
Hormones: growth hormone [GH], i.e. somatotropin
From animals; from humans: growth factors; Growth regulators
Cytokines; Lymphokines; Interferons: tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
Cytokines; Lymphokines; Interferons: colony stimulating factors [CSF]
Term end not estimated
infections, cancer and diabetes, autism, and conditions such as inflammation, joint and muscle pain, muscle weakness, fatigue, sinus and nasal congestion, breathing difficulties, poor digestion, neuropathy, headaches, reduced mental acuity, poor memory, skin conditions, poor fitness, weight imbalances, and a variety of psychological conditions, such as mood swings, depression, anxiety, confusion and anger, and relates more particularly to the use of homeopathic preparations of one or more growth factors to treat such disorders. Use of the homeopathic preparations of the present invention have also surprisingly been demonstrated to increase lean muscle mass while reducing body fat, and improve overall health, fitness and mental clarity.
This invention also relates to homeopathic preparations comprising one or more purified protein(s), such as growth factors, including growth hormone and related molecules, cyclins, and other proteins and peptides, as well as methods and systems for delivery of such preparations and treatment of disorders and conditions by administering such preparations.
This invention additionally relates to providing an effect treatment to restore functional immunity and improving G1 tract function.
FIG. 1 is a sinusoidal curve demonstrating the stimulating and inhibiting effects of homeopathic and allopathic medicines.
FIGS. 2A and B show electrical conductance points for the hand and foot as determined by Voll.
FIG. 3 shows the different outputs measured by the LISTEN system.
The homeopathic preparations of the present invention typically comprise between 1×10−6 and 1×10−100,000 molar concentrations of growth factor in a pharmaceutically acceptable diluent. Various diluents may be used, depending on the appropriate delivery system. Appropriate diluents for the following delivery systems are well known: oral administration in liquid or solid form; intravenous administration; injection; eye drops; nasal sprays; and topical administration. One or more potencies of a specified growth factor and/or one or more growth factors may be combined in a preparation. The preferred homeopathic diluent for oral administration is a solution of purified water, glycerin, citric acid and a preservative such as sodium benzoate. Other diluents for oral delivery, including various alcohol-containing solutions, are known in the art and may be employed in the present invention to increase solubility and stability of growth factors. The homeopathic dilutions of the present invention are preferably administered orally, but may also be prepared in topical formulations for application to the skin, administered transdermally, administered in the form of eye drops, injected into acupuncture or skin conductance points, or administered intravenously. In a preferred embodiment, homeopathic dilutions of growth factors are administered by means of liquids or tablets which retain the memory of the homeopathic dilution. The tablets are made from a suitable organic material, such as lactose (Botanical Labs., Bellingham, Wash.) by methods well known in homeopathy (see, for example, the United States Homeopathic Pharmacopeia). Alternative methods of administration may also be used, such as topical application. Example 1 describes the preliminary results of a double-blind placebo controlled clinical study evaluating the effects of administration of homeopathic dilutions of growth factors on lymphocyte counts in HIV patients using liquid dilutions. Example 8 describes treatment of a patient with insulin dependent diabetes with a homeopathic preparation of insulin-like growth factor (IGF-1) in solution. Example 10 illustrates the effects of oral administration of homeopathic preparations of growth factors in solution on depression levels in healthy patients diagnosed with clinical depression. Examples 11-19 demonstrate the effectiveness of oral administration of homeopathic preparations of growth factors in solution to improve various conditions that represent an imbalance in homeostasis.
Radio frequency signals corresponding to homeopathic dilutions of growth factors may be administered as illustrated by Examples 2-7 and 9, in which Example 2 describes a one time evaluation of homeopathic growth factor signals on HIV-positive patients; Example 3 demonstrates the effect of repeated administrations of homeopathic growth factor signals on two HIV-positive patients compared to a control patient who was not treated with radio frequency signals corresponding to homeopathic dilutions of growth factors; Example 4 shows a four-year longitudinal study of an HIV-positive patient treated with homeopathic growth factor signals; Example 5 describes the effects of administration of homeopathic growth factor signals on patients with Epstein-Barr viral infections (EBV); Example 6 describes the treatment of two cancer patients with signals corresponding to homeopathic growth factors; Example 7 demonstrates the effects of administration of homeopathic growth factor signals to a patient with chronic lymphocytic leukemia; Example 9 demonstrates the effects of administration of homeopathic growth factor signals to two diabetic patients,
In Examples 2-7 and 9, patients were treated using the Life Information System TEN (LISTEN) (BioSource, Inc., Orem, Utah) which determines skin resistance or electrical conductance. The basic tenet behind the LISTEN system is that the points on the body normally referred to as “acupuncture points” have an optimal electrical resistance (100,000 ohms) in healthy subjects which changes during illness. Each acupuncture point is associated with a specific meridian, or line of electrical conductance, which in turn is associated with a particular organ or system of the body (Voll, R. 1977 Topographic positions of the measurement points in electro-acupuncture. 1st English edition, H. Schuldt translator, Medizinish Literarische Verlagsgesellschaft mbH, C. Beckers Buchdruckerei GmbH & Co. KG, M. Sc. Uelzen, Germany, vols 1-4 + supplement). Furthermore, Voll showed that the electrical activity at each of these points is related to the functional status of the specific organ or system (See, for example, Am. J. Acupuncture 8:97-104, 1980). FIGS. 2A and 2B illustrate hand and foot conductance points as defined by Voll. Points coded LY are related to lymph tissue, LU to lung tissue, LA to large intestine, NE to the nervous system, TR to neuroendocrine points, SP to spleen and PA to the pancreas.